BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33068220)

  • 1. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer.
    Harada T; Imai H; Fumita S; Noriyuki T; Gamoh M; Okamoto M; Akashi Y; Kizawa Y; Tokoro A
    Int J Clin Oncol; 2021 Jan; 26(1):104-110. PubMed ID: 33068220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with lung cancer.
    Imai H; Fumita S; Harada T; Noriyuki T; Gamoh M; Okamoto M; Akashi Y; Kizawa Y; Tokoro A
    Jpn J Clin Oncol; 2021 Mar; 51(3):444-450. PubMed ID: 33157554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer.
    Fumita S; Imai H; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y; Tokoro A
    J Pain Symptom Manage; 2020 May; 59(5):1043-1051.e2. PubMed ID: 31805362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of opioid-induced constipation in Japanese patients with cancer pain: A prospective observational cohort study.
    Tokoro A; Imai H; Fumita S; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y
    Cancer Med; 2019 Aug; 8(10):4883-4891. PubMed ID: 31231974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of naldemedine treatment for opioid-induced constipation in gastrointestinal cancer: a retrospective analysis.
    Nishiba H; Imai H; Fujita Y; Hiruta E; Masuno T; Yamazaki S; Tanaka H; Kamiya T; Ito M; Takei S; Matsuura M; Mogi J; Obayashi K; Minato K
    Ann Palliat Med; 2023 Jul; 12(4):697-707. PubMed ID: 37081703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.
    Cobo Dols M; Beato Zambrano C; Cabezón Gutiérrez L; Chicas Sett R; Blancas López-Barajas MI; García Navalón F; Fírvida Pérez JL; Serrano Bermúdez G; Togores Torres P; Delgado Mingorance I; Giraldo Marín A; Librán Oriol A; Paredes Lario A; Sánchez Mauriño P; Higuera Gómez O; Moreno Muñoz D; Jiménez López AJ; Huerta González I; Sanz Yagüe A; Soler López B
    BMJ Support Palliat Care; 2021 Mar; 11(1):25-31. PubMed ID: 32376758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating Clinical Findings into the Patient's Perspective: Post-hoc Pooled Analysis of Bowel Movement Changes as a Predictor of Improvement in Patients' Opioid-induced Constipation Symptoms and Outcomes.
    Coyne KS; Poon JL; Thompson C; Hu Y; Datto CJ; Sostek M
    Clin Ther; 2017 Jan; 39(1):75-88. PubMed ID: 27938897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid-induced constipation in patients with cancer: a "real-world," multicentre, observational study of diagnostic criteria and clinical features.
    Davies A; Leach C; Butler C; Gregory A; Henshaw S; Minton O; Shorthose K; Batsari KM
    Pain; 2021 Jan; 162(1):309-318. PubMed ID: 32701649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-Induced Constipation in Patients with Cancer Pain in Japan (OIC-J Study): A Post Hoc Analysis.
    Tokoro A; Imai H; Fumita S; Harada T; Noriyuki T; Gamoh M; Okamoto M; Akashi Y; Kizawa Y
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.
    LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS
    J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation.
    Lemaire A; Pointreau Y; Narciso B; Piloquet FX; Braniste V; Sabaté JM
    Support Care Cancer; 2021 Dec; 29(12):7577-7586. PubMed ID: 34120247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Opioid-Induced Constipation in Patients with Cancer Pain].
    Aruga E
    Gan To Kagaku Ryoho; 2021 Nov; 48(11):1311-1315. PubMed ID: 34795117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare resource use and costs of opioid-induced constipation among non-cancer and cancer patients on opioid therapy: A nationwide register-based cohort study in Denmark.
    Søndergaard J; Christensen HN; Ibsen R; Jarbøl DE; Kjellberg J
    Scand J Pain; 2017 Apr; 15():83-90. PubMed ID: 28850356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium hydroxide versus macrogol/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients: study protocol for an open-label, randomized controlled trial (the OMAMA study).
    Kistemaker KRJ; de Graeff A; Crul M; de Klerk G; van de Ven PM; van der Meulen MP; van Zuylen L; Steegers MAH
    BMC Palliat Care; 2023 Mar; 22(1):22. PubMed ID: 36915062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Burden of Illness of Rome IV Chronic Idiopathic Constipation, Opioid-Induced Constipation, and Opioid-Exacerbated Constipation in the United States.
    Liang J; Almario CV; Chey WD; Higgins CS; Spiegel BMR
    Am J Gastroenterol; 2023 Nov; 118(11):2033-2040. PubMed ID: 37335135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid-induced constipation, use of laxatives, and health-related quality of life.
    Christensen HN; Olsson U; From J; Breivik H
    Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and impact of constipation and bowel dysfunction induced by strong opioids: a cross-sectional survey of 520 patients with cancer pain: DYONISOS study.
    Abramowitz L; Béziaud N; Labreze L; Giardina V; Caussé C; Chuberre B; Allaert FA; Perrot S
    J Med Econ; 2013 Dec; 16(12):1423-33. PubMed ID: 24102123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis.
    Kanbayashi Y; Shimizu M; Ishizuka Y; Sawa S; Yabe K; Uchida M
    PLoS One; 2022; 17(12):e0278823. PubMed ID: 36490241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-marketing surveillance of the safety and effectiveness of naldemedine in the management of opioid-induced constipation in patients with cancer pain in Japan.
    Takata K; Nakazawa M; Honda K; Hashimoto S
    Support Care Cancer; 2022 May; 30(5):3943-3954. PubMed ID: 35044484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Electroacupuncture for Opioid-Induced Constipation in Patients With Cancer in China: A Randomized Clinical Trial.
    Wang W; Liu Y; Yang X; Sun J; Yue Z; Lu D; Zhou K; Sun Y; Hou A; Zang Z; Jin X; Liu C; Wang Y; Yu J; Zhu L; Liu Z
    JAMA Netw Open; 2023 Feb; 6(2):e230310. PubMed ID: 36811861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.